Avon Talcum Powder Lawsuit Ends in $24M Jury Verdict Over Asbestos Exposure
Former janitor indicates Avon failed to warn about the mesothelioma risks from asbestos exposure while working at a cosmetics facility in Chicago.
Former janitor indicates Avon failed to warn about the mesothelioma risks from asbestos exposure while working at a cosmetics facility in Chicago.
Baby Powder cancer settlement will create a $280 million trust to be used to resolve personal injury claims against the two talc suppliers.
IARC finds talc "exhibits key characteristics of carcinogens in human primary cells" that increases the risk of ovarian cancer.
Although two prior bankruptcy attempts by Johnson & Johnson's talcum powder subsidiary were dismissed, the Court determined that it cannot pre-emptively block a third filing based on future potential harm to plaintiffs.
Women who used Johnson's Baby Powder on their genitals now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses
Talcum powder settlement with state governments still leaves about 60,000 lawsuits pending against Johnson & Johnson, involving claims brought by users who developed ovarian cancer and other injuries
Verdict comes as Johnson & Johnson continues to push a $6.5 billion Baby Powder settlement proposal, which seeks to force the resolution of similar ovarian cancer lawsuits through the U.S. Bankruptcy system
Verdict award expected to grow after jury determines punitive damages for mining company plaintiffs say hid the presence of asbestos in its talc.
Findings are certain to bolster tens of thousands of talcum powder lawsuits being pursued against Johnson & Johnson, for failing to warn women about the risk of ovarian cancer.
The third Johnson & Johnson talcum powder bankruptcy settlement comes after judges have previously rejected prior attempts to force claims through the U.S. Bankruptcy system, since the manufacturer faces no financial distress.